glp-1 news today receptor agonists show promise in treating substance use disorders Popular — and expensive —

PMID: 9094161

The full analysis and other data on health costs are available on the Peterson-KFF Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S

Important safety considerations include the risk of pancreatitis (all GLP-1 agonists carry warnings about this), gallbladder disease (more common with greater weight loss), and a caution with semaglutide in patients with pre-existing diabetic retinopathy, where rapid improvement in glucose control may temporarily worsen retinopathy

Unlike conventional Alzheimers drugs targeting amyloid proteins , GLP-1s approach focuses on neuroinflammation and cellular balance, potentially addressing cognitive impairment through multiple pathways, including the reduction of tau hyperphosphorylation and neuronal apoptosis